22 Aug 2017 
                            in Affinity groups 
        
                            published August 2017
            
            The Drug Discovery, Development & Evaluation (DDDE) Affinity Group aims to support members of the Society with interests in all aspects of pharmacology from drug discovery to prescribed use including target identification, drug development, safety pharmacology, conduct of medical research and clinical trials, approval and licensing. DDDE also serves members with interests in natural products and nutraceuticals. Key to this is integrating the interests of members across academic, clinical and industrial settings.